Chemical Properties
| form | Liquid |
| color | Colorless to light yellow |
Foralumab Chemical Properties,Usage,Production
Uses
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells[1].in vivo
Foralumab (NI-0401; 0.6-250 μg; p.o.; daily, for 5 d) delays the rejection of B6Rag2/ skin grafted onto the humanized mice[1].
Foralumab (0.6-250 μg; p.o. and i.h.; daily, for 5 d) prevents skin xenograft rejection in mice with human immune systems[1].
Foralumab (1-15 μg; p.o.; daily, for 5 d) has good bioavailability of intragastric in humanized mice[1].
| Animal Model: | Humanized NOD/SCID IL-2γc/ mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 15 μg |
| Administration: | Oral administration; daily, for 5 days and weekly dosing |
| Result: | Showed robust protection against graft rejection and prolongs graft survival. Reduced proliferation of CD8+ T cells and reduced release of TNF. Increased the concentration of IL-10. |
| Animal Model: | Humanized NOD/SCID IL-2γc/ mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 1, 5, 15, 50, and 250 μg (p.o.), 0.6 mg/kg (i.h.) |
| Administration: | Oral administration and subcutaneous injection; daily, for 5 days and weekly dosing |
| Result: | Had tolerant to autologous skin grafts in humanized mice. |
| Animal Model: | Humanized NOD/SCID IL-2γc/ mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 0, 5, 10, and 15 μg |
| Administration: | Oral administration and subcutaneous injection; daily, for 5 days and weekly dosing |
| Result: | Increased human Ig on the surface of CD4+ and CD8+ T cells. Had free mAb in the serum of mice |
References
[1] Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246. DOI:10.1016/j.clim.2017.07.005Foralumab Suppliers
Global(23)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 16314854226; +8616314854226 | inquiry@bocsci.com | 19852 | 58 | ||
| 027-027-16602739303 16602739303 | 673003916@qq.com | 4951 | 58 | ||
| 010-60605840 | psaitong@jm-bio.com | 27756 | 58 | ||
| 4008200310 15002144251 | marketing@tsbiochem.com | 24951 | 58 | ||
| 9785721070 | info@cellsciences.com | 6307 | 58 | ||
| 33175446423 | support@antibodysystem.com | 6737 | 58 | ||
| 51288865780 | sales@biosynth.com | 6031 | 58 | ||
| 400-668-6834 | info@selleck.cn | 6061 | 58 | ||
| 029-81124775 17791530730 | 1079@dideu.com | 9998 | 58 | ||
| 027-65317797 15926423062 | 422450190@qq.com | 10300 | 58 |